Janus Henderson Group

Janus Henderson Group Portfolio holdings

AUM $223B
1-Year Est. Return 35%
 

Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.

This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+35%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$223B
AUM Growth
+$4.26B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
2,496
New
Increased
Reduced
Closed

Top Buys

1 +$574M
2 +$573M
3 +$446M
4
MU icon
Micron Technology
MU
+$389M
5
CP icon
Canadian Pacific Kansas City
CP
+$387M

Top Sells

1 +$1.19B
2 +$1.11B
3 +$557M
4
ADSK icon
Autodesk
ADSK
+$554M
5
RNAM
Avidity Biosciences
RNAM
+$490M

Sector Composition

1 Technology 34.83%
2 Healthcare 19.29%
3 Consumer Discretionary 9.89%
4 Financials 9.74%
5 Industrials 9.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LGND icon
201
Ligand Pharmaceuticals
LGND
$4.15B
$188M 0.08%
995,400
-46,978
RTX icon
202
RTX Corp
RTX
$280B
$187M 0.08%
1,019,504
-35,795
ARES icon
203
Ares Management
ARES
$24.4B
$186M 0.08%
1,149,390
+153,488
XENE icon
204
Xenon Pharmaceuticals
XENE
$4.85B
$183M 0.08%
4,084,034
+140,149
AXS icon
205
AXIS Capital
AXS
$7.81B
$181M 0.08%
1,689,901
-81,299
KEYS icon
206
Keysight
KEYS
$48.5B
$180M 0.08%
883,643
+168,698
TYL icon
207
Tyler Technologies
TYL
$15.8B
$177M 0.08%
390,957
-21,602
ZWS icon
208
Zurn Elkay Water Solutions
ZWS
$7.89B
$177M 0.08%
3,810,427
-271,916
STRL icon
209
Sterling Infrastructure
STRL
$12.6B
$176M 0.08%
575,886
+20,299
KMX icon
210
CarMax
KMX
$6.03B
$175M 0.08%
4,530,820
-344,409
OMF icon
211
OneMain Financial
OMF
$6.32B
$171M 0.08%
2,534,271
+1,047,263
TECK icon
212
Teck Resources
TECK
$24.9B
$171M 0.08%
3,564,732
-3,702,261
VZ icon
213
Verizon
VZ
$213B
$170M 0.08%
4,171,670
-119,734
OLMA icon
214
Olema Pharmaceuticals
OLMA
$1.28B
$168M 0.08%
6,710,194
+3,124,345
APO icon
215
Apollo Global Management
APO
$62.5B
$163M 0.07%
1,128,920
+5,528
COGT icon
216
Cogent Biosciences
COGT
$6.01B
$161M 0.07%
4,537,408
+1,359,365
WING icon
217
Wingstop
WING
$6.16B
$161M 0.07%
675,301
+31,618
PLD icon
218
Prologis
PLD
$126B
$161M 0.07%
1,259,369
-480,277
REGN icon
219
Regeneron Pharmaceuticals
REGN
$82.6B
$159M 0.07%
205,672
+131,929
TARS icon
220
Tarsus Pharmaceuticals
TARS
$3.17B
$158M 0.07%
1,930,325
+491,326
APGE icon
221
Apogee Therapeutics
APGE
$5.12B
$156M 0.07%
2,062,604
+1,576,626
NUVL icon
222
Nuvalent
NUVL
$8.04B
$151M 0.07%
1,499,574
-689,100
EMR icon
223
Emerson Electric
EMR
$79.3B
$150M 0.07%
1,128,042
+679,706
TEVA icon
224
Teva Pharmaceuticals
TEVA
$36.7B
$148M 0.07%
4,743,777
-59,696
PEN icon
225
Penumbra
PEN
$13.3B
$148M 0.07%
475,898
+7,050